| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 02/03/2010 | EP1963269B1 Process for amination of acrylic macromonomers and products therefrom |
| 02/03/2010 | CN101641330A Novel benzamide derivatives and process for the preparation thereof |
| 02/03/2010 | CN101638379A Preparation method for dihydropyridine type compound |
| 02/03/2010 | CN101638378A Synthetic method of N-alkyl substituted-3-piperidones |
| 02/03/2010 | CN100586963C Alkoxyamines containing a radical polymerization group |
| 02/02/2010 | US7655804 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 02/02/2010 | US7655675 Gamma-secretase inhibitors |
| 02/02/2010 | US7655663 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 02/02/2010 | US7655653 Tetrahydrobenzfluorene derivatives |
| 02/02/2010 | CA2454830C Substituted urea neuropeptide y y5 receptor antagonists |
| 02/02/2010 | CA2396158C Dipeptide nitrile cathepsin k inhibitors |
| 02/02/2010 | CA2358581C Arylalkanoyl derivatives, processes for their preparation, their use and pharmaceutical compositions containing them |
| 02/02/2010 | CA2333963C Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds |
| 02/02/2010 | CA2324418C Novel opiate compounds, methods of making and methods of use |
| 02/02/2010 | CA2294809C Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same |
| 01/28/2010 | WO2010010288A2 Alkylthiazol carbamate derivatives, preparation thereof and therapeutic use thereof |
| 01/28/2010 | WO2010009508A1 Antiparasitic compounds |
| 01/28/2010 | US20100022773 Apoptosis promoters |
| 01/28/2010 | US20100022595 Benzenesulfonamide Compounds and Their Use as Blockers of Calcium Channels |
| 01/28/2010 | US20100022394 Products for the treatment of the iron chlorosis |
| 01/28/2010 | US20100021541 Microparticulate form of a Tetrahydropyridine derivative |
| 01/28/2010 | CA2731789A1 Alkyl thiazole carbamate derivatives, preparation thereof, and use thereof as faah enzyme inhibitors |
| 01/27/2010 | EP2147002A1 Bisamide-zinc bases |
| 01/27/2010 | EP2146961A1 N-oxide and/or di-n-oxide derivatives of dopamine receptor stabilizers/modulators displaying improved cardiovascular side-effects profiles |
| 01/27/2010 | EP2146960A2 Synthesis of n-(4-fluorobenzyl)-n-(l-methylpiperidin-4-yl)-n'-(4- (2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms |
| 01/27/2010 | EP2146959A1 Vanilloid receptor ligands and the use thereof for the production of pharmaceuticals |
| 01/27/2010 | EP2146957A1 Quaternary ammonium compounds useful as muscarinic receptor antagonists |
| 01/27/2010 | EP2146952A1 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase |
| 01/27/2010 | EP2146951A2 Novel rar receptor agonist ligands and use thereof in human medicine and cosmetics |
| 01/27/2010 | EP1303503B1 Aniline derivatives |
| 01/26/2010 | US7652135 Compositions useful as inhibitors of protein kinases |
| 01/26/2010 | CA2338854C Nitric esters and nitrate salts of specific drugs |
| 01/21/2010 | WO2010007561A1 Novel compounds active as muscarinic receptor antagonists |
| 01/21/2010 | WO2010007552A1 Novel compounds active as muscarinic receptor antagonists |
| 01/21/2010 | WO2010007248A2 Novel tricyclic derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 01/21/2010 | WO2010007027A1 Selective hydroxamic acid based mmp-12 and mmp-13 inhibitors |
| 01/21/2010 | WO2010006725A1 Insecticidal compounds |
| 01/21/2010 | WO2008107797A3 Lercanidipine hydrochloride polymorphs and an improved process for preparation of 1,1,n-trimethyl-n-(3,3-diphenylpropyl)-2-aminoethyl acetoacetate |
| 01/21/2010 | US20100016602 Novel arylamidine derivative, salt thereof and antifungal agent containing those |
| 01/21/2010 | US20100016601 Process for preparing remifentanil, intermediates thereof, use of said intermediates and processes for the preparation thereof |
| 01/21/2010 | US20100016600 N- and O-Substituted 4-[2-(Diphenylmethoxy)-Ethyl]-1-[(Phenyl)Methyl]Piperdine Analogs and Methods of Treating CNS Disorders Therewith |
| 01/21/2010 | US20100016599 Process for Preparing Fexofenadine |
| 01/21/2010 | US20100016598 Alpha7 nicotinic acetylcholine receptor inhibitors |
| 01/21/2010 | US20100016410 Methods and Compositions Related to Eosinophil Regulation |
| 01/21/2010 | US20100016376 Caspase inhibitors based on pyridone scaffold |
| 01/21/2010 | US20100016374 Compounds Which Inhibit the Glycine Transporter and Uses Thereof |
| 01/21/2010 | US20100016366 Novel Compounds Active as Muscarinic Receptor Antagonists |
| 01/21/2010 | US20100016365 Substituted 4-amino-piperidines |
| 01/21/2010 | US20100016347 Series of skin whitening (lightening) compounds |
| 01/21/2010 | US20100016295 Preparation and Use of Biphenyl Amino Acid Derivatives for the Treatment of Obesity |
| 01/21/2010 | US20100016286 Anti-Inflammatory Agents |
| 01/21/2010 | US20100016278 Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals |
| 01/21/2010 | US20100015130 Disc-1 pathway activators in the control of neurogenesis |
| 01/21/2010 | CA2768183A1 Targeted nitroxide agents |
| 01/21/2010 | CA2730708A1 Selective hydroxamic acid based mmp-12 and mmp-13 inhibitors |
| 01/21/2010 | CA2730516A1 Novel tricyclic derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 01/21/2010 | CA2727769A1 Novel compounds active as muscarinic receptor antagonists |
| 01/20/2010 | EP1805141B1 Piperidines and related compounds for treatment of alzheimer's disease |
| 01/20/2010 | EP1758858B1 Cosmetic use of piperidine derivatives |
| 01/20/2010 | EP1675812B1 Bridged ring structures as pharmaceutical agents |
| 01/20/2010 | EP1202961B1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 01/20/2010 | CN101631774A Symmetric azo compounds in flame retardant compositions |
| 01/20/2010 | CN101628889A Method for preparing improved donepezil hydrochloride key intermediate |
| 01/20/2010 | CN100582094C Process for preparing 3,4,5-trihydroxy piperidine alkaloid |
| 01/19/2010 | US7649095 Piperidine derivatives and agent comprising the derivative as active ingredient |
| 01/19/2010 | US7649014 Inhibit uncoupling protein-2 (UCP2); treating deficient first-phase insulin secretion, non-insulin dependent diabetes mellitus, and ischemia |
| 01/19/2010 | US7649011 Inhibitors of human tumor-expressed CCXCKR2 |
| 01/19/2010 | US7649001 Fused benzene derivative and use |
| 01/19/2010 | US7649000 (2'S,2''R)-4-(2'-(2''-amino-3''-(4'''-ethoxyphenyl)propanoylamino)-3'-phenylpropanoyl-amino)piperidine- 1-carboxamidine; inflammatory bowel disease, arthritis, inflammation, septic shock, hypotension, cancer, adult respiratory distress syndrome, disseminated intravascular coagulation |
| 01/19/2010 | US7648990 Chemical compounds |
| 01/19/2010 | CA2427660C Biphenylcarboxamides useful as lipid lowering agents |
| 01/14/2010 | WO2010006191A1 4-phenoxymethylpiperidines as modulators of gpr119 activity |
| 01/14/2010 | WO2010005807A2 Novel inhibitors of proliferation and activation of signal transducer and activator of transcription (stats) |
| 01/14/2010 | WO2010005783A1 Pyrrolidinyl and piperidinyl compounds useful as nhe-1 inhibitors |
| 01/14/2010 | WO2010004347A1 Heterocyclic gpcr agonists |
| 01/14/2010 | WO2010004269A2 Stereospecific synthesis |
| 01/14/2010 | US20100010229 Fexofenadine polymorph |
| 01/14/2010 | US20100010228 Process for the asymmetric reduction of 3-benzoylpiperidines |
| 01/14/2010 | US20100010227 Process for production of piperidine derivatives |
| 01/14/2010 | US20100010043 Percutaneously absorbable preparation |
| 01/14/2010 | US20100010041 Difluorinated piperidines for treatment of alzheimer's disease and related conditions |
| 01/14/2010 | US20100010010 Hdac inhibitors |
| 01/14/2010 | US20100010004 Inhibitors of histone deacetylase |
| 01/14/2010 | US20100009991 Polycyclic acid compounds useful as crth2 antagonists and antiallergic agents |
| 01/14/2010 | US20100009988 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 01/14/2010 | CA2730511A1 4-phenoxymethylpiperidines as modulators of gpr119 activity |
| 01/14/2010 | CA2730116A1 Pyrrolidinyl and piperidinyl compounds useful as nhe-1 inhibitors |
| 01/14/2010 | CA2729943A1 Novel inhibitors of proliferation and activation of signal transducer and activator of transcription (stats) |
| 01/13/2010 | EP2143444A1 Compositions for inhibition of anglogenesis |
| 01/13/2010 | EP2143420A1 Formulation comprising mutant/s of lysosomal alpha-galactosidase A for the treatment of Fabry disease |
| 01/13/2010 | EP2142505A1 Sulfonamides and pharmaceutical compositions thereof |
| 01/13/2010 | EP2141994A1 Multi-ring compounds and uses thereof |
| 01/13/2010 | EP1575911B1 Biaromatic compounds which activate ppar-gamma type receptors and use thereof in cosmetic or pharmaceutical compositions |
| 01/13/2010 | EP1435954B1 A PROCESS FOR THE PREPARATION OF HIGHlLY PUREAMLODIPINE BENZENESULFONATE |
| 01/13/2010 | EP1144388B1 Acyl derivatives which treat vla-4 related disorders |
| 01/13/2010 | CN101624368A Process for producing arecoline hydrobromide |
| 01/13/2010 | CN100579957C Novel arylamidine derivative or salt thereof |
| 01/12/2010 | US7645799 thromboembolic and/or inflammatory disorders; 4-Aminomethyl-cyclohexanecarboxylic acid (1-biphenyl-3-yl-2-phenyl-ethyl)-amide; selective inhibitors of serine protease enzymes of the coagulation cascade and/or contact activation system; improved pharmacological properties, plasma kallikrein activity |
| 01/12/2010 | US7645797 Gamma aminobutyric acid antagonist such as naphthylalanine; antiepileptic agents; antidepressants; anxiolytic agents; psychological disorders; neurodegenerative diseases; analgesics; drug withdrawal |
| 01/12/2010 | US7645774 Sulfonamide-containing benzene derivatives; cancer and inflammatory, immunomodulatory or respiratory diseases; allergy, seasonal allergic rhinitis, reversible airway obstruction, adult respiratory distress syndrome, asthma, or bronchitis |